Case Type: Mergers & Acquisitions

SolarWinds Corporation (NYSE: SWI), relating to the proposed merger with Turn/River Capital. Under the terms of the agreement, stockholders of SolarWinds will receive $18.50 per share in cash.

Bridge Investment Group Holdings Inc. (NYSE: BRDG), relating to the proposed merger with Apollo. Under the terms of the agreement, Bridge stockholders and Bridge OpCo unitholders will receive 0.07081 shares of Apollo stock for each share of Bridge Class A common stock and each Bridge OpCo Class A common unit, respectively.

bluebird bio, Inc. (Nasdaq: BLUE), relating to the proposed merger with Beacon Parent Holdings, L.P. Under the terms of the agreement, bluebird stockholders will receive $3.00 per share and a contingent value right per share of $6.84 in cash if bluebird’s current product portfolio achieves $600 million in net sales in a 12-month period before … Read more

Global Blue Group Holding AG (NYSE: GB), relating to the proposed merger with Shift4 Payments, Inc. Under the terms of the agreement, Shift4 intends to acquire Global Blue for $7.50 per common share in cash.

Jet.AI Inc. (Nasdaq: JTAI), relating to the proposed merger with flyExclusive Inc. Under the terms of the agreement, Jet.AI shareholders will retain their Jet.AI stock and receive new Class A common shares in flyExclusive as part of the transaction.

Welsbach Technology Metals Acquisition Corp. (Nasdaq: WTMA), relating to the proposed merger with Evolution Metals LLC. Under the terms of the agreement, EM shareholders will become shareholders in the surviving public company, Evolution Metals & Technologies Corp.

Intevac, Inc. (Nasdaq: IVAC), relating to the proposed merger with Seagate Technology Holdings plc. Under the terms of the agreement, Seagate will acquire Intevac in an all-cash transaction for $4.00 per share.

Playa Hotels & Resorts N.V. (Nasdaq: PLYA), relating to the proposed merger with Hyatt Hotels Corporation. Under the terms of the agreement, Hyatt will acquire all outstanding shares of Playa for $13.50 per share in cash.

Acelyrin, Inc. (Nasdaq: SLRN), relating to the proposed merger with Alumis Inc. Under the terms of the agreement, Acelyrin stockholders will receive 0.4274 shares of Alumis common stock per share of common stock owned. Upon the close of the transaction, Acelyrin stockholders will own approximately 45% of the combined company.

Nevro Corp. (NYSE: NVRO), relating to the proposed merger with Globus Medical. Under the terms of the agreement, Globus Medical will acquire all shares of Nevro for $5.85 per share.